Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Gagné K[au]:

Search results

Items: 1 to 50 of 64

1.

Deaf ACCESS: Adapting Consent Through Community Engagement and State-of-the-Art Simulation.

Anderson ML, Riker T, Hakulin S, Meehan J, Gagne K, Higgins T, Stout E, Pici-D'Ottavio E, Cappetta K, Wolf Craig KS.

J Deaf Stud Deaf Educ. 2019 Nov 29. pii: enz035. doi: 10.1093/deafed/enz035. [Epub ahead of print]

PMID:
31782774
2.

Development and evaluation of an online infertility peer supporter training program.

Grunberg PH, Dennis CL, Da Costa D, Gagné K, Idelson R, Zelkowitz P.

Patient Educ Couns. 2019 Nov 18. pii: S0738-3991(19)30526-9. doi: 10.1016/j.pec.2019.11.019. [Epub ahead of print]

PMID:
31761526
3.

Waiting for the flood: technocratic time and impending disaster in the Himalayas.

Gagné K.

Disasters. 2019 Oct;43(4):840-866. doi: 10.1111/disa.12379. Epub 2019 Jul 11.

PMID:
31294489
4.

Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide.

Willem C, Makanga DR, Guillaume T, Maniangou B, Legrand N, Gagne K, Peterlin P, Garnier A, Béné MC, Cesbron A, Le Bourgeois A, Chevallier P, Retière C.

J Immunol. 2019 Apr 1;202(7):2141-2152. doi: 10.4049/jimmunol.1801489. Epub 2019 Feb 20.

PMID:
30787107
5.

A Dual Mode Propulsion System for Small Satellite Applications.

Gagne KR, McDevitt MR, Hitt DL.

Aerospace (Basel). 2018;5(2):52. doi: 10.3390/aerospace5020052. Epub 2018 May 2.

6.

Deaf Qualitative Health Research: Leveraging Technology to Conduct Linguistically and Sociopolitically Appropriate Methods of Inquiry.

Anderson ML, Riker T, Gagne K, Hakulin S, Higgins T, Meehan J, Stout E, Pici-D'Ottavio E, Cappetta K, Wolf Craig KS.

Qual Health Res. 2018 Sep;28(11):1813-1824. doi: 10.1177/1049732318779050. Epub 2018 Jun 11.

7.

Corrigendum: Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients.

Dugast E, David G, Oger R, Danger R, Judor JP, Gagne K, Chesneau M, Degauque N, Soulillou JP, Paul P, Picard C, Guerif P, Conchon S, Giral M, Gervois N, Retière C, Brouard S.

Front Immunol. 2018 Mar 26;9:589. doi: 10.3389/fimmu.2018.00589. eCollection 2018.

8.

Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.

Retière C, Willem C, Guillaume T, Vié H, Gautreau-Rolland L, Scotet E, Saulquin X, Gagne K, Béné MC, Imbert BM, Clemenceau B, Peterlin P, Garnier A, Chevallier P.

Oncotarget. 2018 Jan 27;9(14):11451-11464. doi: 10.18632/oncotarget.24328. eCollection 2018 Feb 20.

9.

Broad Impairment of Natural Killer Cells from Operationally Tolerant Kidney Transplanted Patients.

Dugast E, David G, Oger R, Danger R, Judor JP, Gagne K, Chesneau M, Degauque N, Soulillou JP, Paul P, Picard C, Guerif P, Conchon S, Giral M, Gervois N, Retière C, Brouard S.

Front Immunol. 2017 Dec 11;8:1721. doi: 10.3389/fimmu.2017.01721. eCollection 2017. Erratum in: Front Immunol. 2018 Mar 26;9:589.

10.

Next-generation sequencing technology a new tool for killer cell immunoglobulin-like receptor allele typing in hematopoietic stem cell transplantation.

Maniangou B, Retière C, Gagne K.

Transfus Clin Biol. 2018 Feb;25(1):87-89. doi: 10.1016/j.tracli.2017.07.005. Epub 2017 Oct 12.

PMID:
29032017
11.

Killer Immunoglobulin-Like Receptor Allele Determination Using Next-Generation Sequencing Technology.

Maniangou B, Legrand N, Alizadeh M, Guyet U, Willem C, David G, Charpentier E, Walencik A, Retière C, Gagne K.

Front Immunol. 2017 May 19;8:547. doi: 10.3389/fimmu.2017.00547. eCollection 2017.

12.

Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.

Riou R, Bressollette-Bodin C, Boutoille D, Gagne K, Rodallec A, Lefebvre M, Raffi F, Senitzer D, Imbert-Marcille BM, Retière C.

J Virol. 2017 Feb 14;91(5). pii: e02245-16. doi: 10.1128/JVI.02245-16. Print 2017 Mar 1.

13.

[Polymorphism in HLA and KIR genes and the impact on hematopoietic stem cell transplantation outcomes and unrelated donor selection: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Dubois V, Brignier A, Elsermans V, Gagne K, Kennel A, Pedron B, Picard C, Ravinet A, Varlet P, Cesbron A, Delbos F, Yakoub-Agha I, Loiseau P.

Bull Cancer. 2016 Nov;103(11S):S243-S247. doi: 10.1016/j.bulcan.2016.09.005. Epub 2016 Nov 14. French.

PMID:
27855950
14.

Impact of Graft-Versus-Graft Natural Killer Cell Alloreactivity on Single Unit Dominance After Double Umbilical Cord Blood Transplantation.

Rettman P, Willem C, Volteau C, Legrand N, Chevallier P, Lodé L, Esbelin J, Cesbron A, Bonneville M, Moreau P, Senitzer D, Retière C, Gagne K.

Transplantation. 2017 Sep;101(9):2092-2101. doi: 10.1097/TP.0000000000001545.

PMID:
27798515
15.

Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI).

Rettman P, Malard F, Legrand N, Avinens O, Eliaou JF, Picard C, Dormoy A, Lafarge X, de Matteis M, Kennel A, Loiseau P, Devys A, Boudifa A, Absi L, Fort M, Masson D, Quainon F, Theodorou I, Batho A, Parissiadis A, Delbos F, Drouet M, Senitzer D, Marry E, Raus N, Yakoub-Agha I, Cesbron A, Retière C, Gagne K.

Bone Marrow Transplant. 2016 Nov;51(11):1499-1503. doi: 10.1038/bmt.2016.151. Epub 2016 Jun 6. No abstract available.

PMID:
27272444
16.

Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.

Carapito R, Jung N, Kwemou M, Untrau M, Michel S, Pichot A, Giacometti G, Macquin C, Ilias W, Morlon A, Kotova I, Apostolova P, Schmitt-Graeff A, Cesbron A, Gagne K, Oudshoorn M, van der Holt B, Labalette M, Spierings E, Picard C, Loiseau P, Tamouza R, Toubert A, Parissiadis A, Dubois V, Lafarge X, Maumy-Bertrand M, Bertrand F, Vago L, Ciceri F, Paillard C, Querol S, Sierra J, Fleischhauer K, Nagler A, Labopin M, Inoko H, von dem Borne PA, Kuball J, Ota M, Katsuyama Y, Michallet M, Lioure B, Peffault de Latour R, Blaise D, Cornelissen JJ, Yakoub-Agha I, Claas F, Moreau P, Milpied N, Charron D, Mohty M, Zeiser R, Socié G, Bahram S.

Blood. 2016 Oct 13;128(15):1979-1986. Epub 2016 Aug 22.

17.

Multidimensional reduction of multicentric cohort heterogeneity: An alternative method to increase statistical power and robustness.

Le Gall C, Laurent J, Vince N, Lizee A, Agrawal A, Walencik A, Rettman P, Gagne K, Retiere C, Hollenbach J, Cesbron A, Limou S, Gourraud PA.

Hum Immunol. 2016 Nov;77(11):1024-1029. doi: 10.1016/j.humimm.2016.05.013. Epub 2016 Jun 1.

PMID:
27262455
18.

Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells.

Djaoud Z, Riou R, Gavlovsky PJ, Mehlal S, Bressollette C, Gérard N, Gagne K, Charreau B, Retière C.

J Innate Immun. 2016;8(4):374-85. doi: 10.1159/000445320. Epub 2016 Apr 27.

19.

New insights on the natural killer cell repertoire from a thorough analysis of cord blood cells.

Rettman P, Willem C, David G, Riou R, Legrand N, Esbelin J, Cesbron A, Senitzer D, Gagne K, Retière C.

J Leukoc Biol. 2016 Sep;100(3):471-9. doi: 10.1189/jlb.1HI0116-036R. Epub 2016 Apr 11.

PMID:
27067451
20.

Natural killer cell licensing after double cord blood transplantation is driven by the self-HLA class I molecules from the dominant cord blood.

Guillaume N, Loiseau P, Gagne K, Teissserenc HM, Cayuela JM, Henry G, Robin M, Peffault de Latour R, Gluckman E, Socié G, Retiere C, Dulphy N, Toubert A.

Haematologica. 2016 May;101(5):e209-12. doi: 10.3324/haematol.2015.138883. Epub 2016 Jan 27. No abstract available.

21.

Extracellular signaling molecules to promote fracture healing and bone regeneration.

Hankenson KD, Gagne K, Shaughnessy M.

Adv Drug Deliv Rev. 2015 Nov 1;94:3-12. doi: 10.1016/j.addr.2015.09.008. Epub 2015 Sep 30. Review.

PMID:
26428617
22.

Use of killer cell immunoglobulin-like receptor genes as early markers of hematopoietic chimerism after double-umbilical cord blood transplantation.

Rettman P, Legrand N, Willem C, Lodé L, Chevallier P, Cesbron A, Senitzer D, Retière C, Gagne K.

Haematologica. 2015 Nov;100(11):e475-9. doi: 10.3324/haematol.2015.127993. Epub 2015 Jul 23. No abstract available.

23.

Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study.

Gagne K, Loiseau P, Dubois V, Dufossé F, Perrier P, Dormoy A, Jollet I, Renac V, Masson D, Picard C, Lafarge X, Hanau D, Quainon F, Delbos F, Coeffic B, Absi L, Eliaou JF, Moalic V, Fort M, de Matteis M, Theodorou I, Hau F, Batho A, Pedron B, Caillat-Zucman S, Marry E, Raus N, Yakoub-Agha I, Cesbron A.

Bone Marrow Transplant. 2015 Feb;50(2):232-6. doi: 10.1038/bmt.2014.253. Epub 2014 Nov 3.

PMID:
25365066
24.

Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.

Le Bourgeois A, Labopin M, Guillaume T, Delaunay J, Foucher Y, Tessoulin B, Malard F, Ayari S, Peterlin P, Derenne S, Herry P, Cesbron A, Gagne K, Lodé L, Illiaquer M, Imbert-Marcille BM, Le Gouill S, Moreau P, Mohty M, Chevallier P.

Exp Hematol. 2014 Nov;42(11):945-54. doi: 10.1016/j.exphem.2014.07.264. Epub 2014 Jul 26.

PMID:
25072620
25.

Sequential internal thoracic artery bypass is safe but does not improve survival.

Gagné K, Deschamps A, Cartier R.

Ann Thorac Surg. 2014 Jul;98(1):23-9. doi: 10.1016/j.athoracsur.2014.03.036. Epub 2014 May 13.

PMID:
24835151
26.

Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia.

Gagne KE, Ghazvinian R, Yuan D, Zon RL, Storm K, Mazur-Popinska M, Andolina L, Bubala H, Golebiowska S, Higman MA, Kalwak K, Kurre P, Matysiak M, Niewiadomska E, Pels S, Petruzzi MJ, Pobudejska-Pieniazek A, Szczepanski T, Fleming MD, Gazda HT, Agarwal S.

Blood. 2014 Jul 17;124(3):437-40. doi: 10.1182/blood-2014-01-545830. Epub 2014 Apr 15.

27.

Natural killer cells and killer-cell immunoglobulin-like receptor polymorphisms: their role in hematopoietic stem cell transplantation.

Schellekens J, Gagne K, Marsh SG.

Methods Mol Biol. 2014;1109:139-58. doi: 10.1007/978-1-4614-9437-9_9. Review.

PMID:
24473783
28.

Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.

David G, Djaoud Z, Willem C, Legrand N, Rettman P, Gagne K, Cesbron A, Retière C.

J Immunol. 2013 Nov 1;191(9):4778-88. doi: 10.4049/jimmunol.1301580. Epub 2013 Sep 27.

29.

Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells.

Djaoud Z, David G, Bressollette C, Willem C, Rettman P, Gagne K, Legrand N, Mehlal S, Cesbron A, Imbert-Marcille BM, Retière C.

J Immunol. 2013 Sep 1;191(5):2708-16. doi: 10.4049/jimmunol.1301138. Epub 2013 Aug 5.

30.

Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population.

Gagne K, Willem C, Legrand N, Djaoud Z, David G, Rettman P, Bressollette-Bodin C, Senitzer D, Esbelin J, Cesbron-Gautier A, Schneider T, Retière C.

Eur J Immunol. 2013 Apr;43(4):1085-98. doi: 10.1002/eji.201243007. Epub 2013 Mar 4.

31.

Induced pluripotent stem cells with a mitochondrial DNA deletion.

Cherry AB, Gagne KE, McLoughlin EM, Baccei A, Gorman B, Hartung O, Miller JD, Zhang J, Zon RL, Ince TA, Neufeld EJ, Lerou PH, Fleming MD, Daley GQ, Agarwal S.

Stem Cells. 2013 Jul;31(7):1287-97. doi: 10.1002/stem.1354.

32.

CTC1 Mutations in a patient with dyskeratosis congenita.

Keller RB, Gagne KE, Usmani GN, Asdourian GK, Williams DA, Hofmann I, Agarwal S.

Pediatr Blood Cancer. 2012 Aug;59(2):311-4. doi: 10.1002/pbc.24193. Epub 2012 Apr 24.

33.

Investigation of the impact of HLA-DPB1 matching status in 10/10 HLA matched unrelated hematopoietic stem cell transplantation: results of a French single center study.

Touzeau C, Gagne K, Sébille V, Herry P, Chevallier P, Folléa G, Devys A, Moreau P, Mohty M, Cesbron Gautier A.

Hum Immunol. 2012 Jul;73(7):711-4. doi: 10.1016/j.humimm.2012.03.013. Epub 2012 Apr 12.

PMID:
22504408
34.

Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy.

Dubois V, Sloan-Béna F, Cesbron A, Hepkema BG, Gagne K, Gimelli S, Heim D, Tichelli A, Delaunay J, Drouet M, Jendly S, Villard J, Tiercy JM.

Leukemia. 2012 Sep;26(9):2079-85. doi: 10.1038/leu.2012.68. Epub 2012 Mar 14.

PMID:
22488219
35.

Improved KIR gene and HLA-C KIR ligand sequence-specific primer polymerase chain reaction genotyping using whole genome amplification.

Chainonthee W, Böttcher G, Gagne K, Füssel M, Bignon JD, Wassmuth R.

Tissue Antigens. 2010 Aug;76(2):135-43. doi: 10.1111/j.1399-0039.2010.01479.x. Epub 2010 Apr 8.

PMID:
20403144
36.

Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.

Gagne K, Busson M, Bignon JD, Balère-Appert ML, Loiseau P, Dormoy A, Dubois V, Perrier P, Jollet I, Bois M, Masson D, Moine A, Absi L, Blaise D, Charron D, Raffoux C; ARS2000 FRM and FGM group.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1366-75. doi: 10.1016/j.bbmt.2009.06.015.

37.

Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.

David G, Morvan M, Gagne K, Kerdudou N, Willem C, Devys A, Bonneville M, Folléa G, Bignon JD, Retière C.

Immunology. 2009 Oct;128(2):172-84. doi: 10.1111/j.1365-2567.2009.03085.x.

38.

Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.

Morvan M, Willem C, Gagne K, Kerdudou N, David G, Sébille V, Folléa G, Bignon JD, Retière C.

J Immunol. 2009 Jun 1;182(11):6727-35. doi: 10.4049/jimmunol.0900212.

39.

Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions.

Morvan M, David G, Sébille V, Perrin A, Gagne K, Willem C, Kerdudou N, Denis L, Clémenceau B, Folléa G, Bignon JD, Retière C.

Eur J Immunol. 2008 Dec;38(12):3474-86. doi: 10.1002/eji.200838407. Erratum in: Eur J Immunol. 2009 Jan;39(1):324.

40.

The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations.

Valentin N, Gagne K, Kerdudou N, Hallé L, Kaplan C, Killie MK, Skogen B, Muller JY, Bignon JD.

Transfusion. 2007 Dec;47(12):2322-9. Epub 2007 Aug 21.

PMID:
17714418
41.

Mapping MHC-resident transplantation determinants.

Malkki M, Gooley TA, Horowitz MM, Absi L, Christiansen FT, Cornelissen JJ, Dormoy A, Dubois V, Gagne K, Gluckman E, Haagenson MD, Oudshoorn M, Spellman S, Petersdorf EW; International Histocompatibility Working Group in Transplantation.

Biol Blood Marrow Transplant. 2007 Aug;13(8):986-95.

42.

HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.

Loiseau P, Busson M, Balere ML, Dormoy A, Bignon JD, Gagne K, Gebuhrer L, Dubois V, Jollet I, Bois M, Perrier P, Masson D, Moine A, Absi L, Reviron D, Lepage V, Tamouza R, Toubert A, Marry E, Chir Z, Jouet JP, Blaise D, Charron D, Raffoux C.

Biol Blood Marrow Transplant. 2007 Aug;13(8):965-74.

43.

Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations.

Gagne K, Busson M, Balere-Appert ML, Absi L, Jollet I, Bignon JD, Bois M, Dormoy A, Dubois V, Gebuhrer L, Loiseau P, Masson D, Moine A, Perrier P, Reviron D, Charron D, Raffoux C; ARS 2000 FRM and FGM group.

Tissue Antigens. 2007 Apr;69 Suppl 1:118-22.

PMID:
17445183
44.

Preliminary analysis of a KIR haplotype estimation algorithm: a simulation study.

Gourraud PA, Gagne K, Bignon JD, Cambon-Thomsen A, Middleton D.

Tissue Antigens. 2007 Apr;69 Suppl 1:96-100.

PMID:
17445177
45.

Distribution of killer-cell immunoglobulin-like receptor (KIR) in Comoros and Southeast France.

Frassati C, Touinssi M, Picard C, Segura M, Galicher V, Papa K, Gagne K, Vivier E, Degioanni A, Böetsch G, Mercier P, Vély F, de Micco P, Reviron D, Chiaroni J.

Tissue Antigens. 2006 May;67(5):356-67.

PMID:
16671942
46.

Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion.

Denis L, Sivula J, Gourraud PA, Kerdudou N, Chout R, Ricard C, Moisan JP, Gagne K, Partanen J, Bignon JD.

Tissue Antigens. 2005 Oct;66(4):267-76.

PMID:
16185321
47.

KIR matching in hematopoietic stem cell transplantation.

Bignon JD, Gagne K.

Curr Opin Immunol. 2005 Oct;17(5):553-9. Review.

PMID:
16085405
48.

NK-KIR transcript kinetics correlate with acute graft-versus-host disease occurrence after allogeneic bone marrow transplantation.

Denis L, Gagne K, Gueglio B, Kerdudou N, Milpied N, Simon P, Follea G, Bonneville M, Harousseau JL, Bignon JD.

Hum Immunol. 2005 May;66(5):447-59. Epub 2005 Feb 19.

PMID:
15935882
49.

Different patterns of TCR beta chain regulation following allo- and xeno-transplantation.

Guillet M, Gagne K, Lair D, Heslan JM, Doré JC, Soulillou JP, Brouard S.

Xenotransplantation. 2004 Jul;11(4):315-22.

PMID:
15196125
50.

Identification of a new HLA-DRB1 allele, DRB1*0321.

Gagne K, Bonneville F, Cheneau ML, Herry P, Pinson MJ, Herfray P, Cesbron-Gautier A, Folléa G, Bignon JD.

Tissue Antigens. 2002 Sep;60(3):268-70.

PMID:
12445312

Supplemental Content

Support Center